Skip to main content
Log in

Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Resistin is an obesity-related adipokine which has also been implicated in bone metabolism. Therefore, we designed a study to investigate the possible role of resistin gene variation in both obesity and bone mineral density. We included 1,155 individuals from the Odense Androgen Study (663 young subjects and 492 older subjects), a population-based, prospective, observational study on the inter-relationship between endocrine status, body composition, muscle function, and bone metabolism in men, in an association study with resistin (RETN) polymorphisms. Three RETN variants (rs1862513, rs3745367 and rs3745369) were genotyped with TaqMan Pre-Designed Genotyping assays. Linear regression was performed to investigate the possible association of these variants with several obesity- and bone-related parameters. After genotyping 1,155 Danish men, 663 young subjects and 492 older subjects, we found that rs3745367 was associated with several obesity-related measures in both the young and elderly cohort. Rs3745369 was only associated with obesity-phenotypes in the elderly cohort. When studying the combined cohorts, we could confirm the associations of rs3745367 with several obesity-related parameters. We were unable to identify any association between RETN polymorphisms and bone-related measurements. Together, these results illustrate resistin’s role in the development of obesity. Rs3745367 gives the most consistent results in the current study and these should be confirmed in other populations. Research into its possible functional effect might also be required. A role for RETN variants in determining bone mineral density seems unlikely from our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307–312

    Article  PubMed  CAS  Google Scholar 

  2. Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276(14):11252–11256

    Article  PubMed  CAS  Google Scholar 

  3. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300(2):472–476

    Article  PubMed  CAS  Google Scholar 

  4. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M (2003) Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300(3):674–678

    Article  PubMed  CAS  Google Scholar 

  5. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (2005) Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 334(4):1092–1101

    Article  PubMed  CAS  Google Scholar 

  6. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1(2):e45

    Article  PubMed  Google Scholar 

  7. Thommesen L, Stunes AK, Monjo M, Grosvik K, Tamburstuen MV, Kjobli E, Lyngstadaas SP, Reseland JE, Syversen U (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 99(3):824–834

    Article  PubMed  CAS  Google Scholar 

  8. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hebert CC (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19(15):4046–4055

    Article  PubMed  CAS  Google Scholar 

  9. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98(2):502–506

    Article  PubMed  CAS  Google Scholar 

  10. Gerstmayer B, Kusters D, Gebel S, Muller T, Van Miert E, Hofmann K, Bosio A (2003) Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern. Genomics 81(6):588–595

    Article  PubMed  CAS  Google Scholar 

  11. Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L (2004) Disulfide-dependent multimeric assembly of resistin family hormones. Science 304(5674):1154–1158

    Article  PubMed  CAS  Google Scholar 

  12. Engert JC, Vohl MC, Williams SM, Lepage P, Loredo-Osti JC, Faith J, Dore C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Despres JP, Gaudet D, Hudson TJ (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes 51(5):1629–1634

    Article  PubMed  CAS  Google Scholar 

  13. Mattevi VS, Zembrzuski VM, Hutz MH (2004) A resistin gene polymorphism is associated with body mass index in women. Hum Genet 115(3):208–212

    Article  PubMed  CAS  Google Scholar 

  14. Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H (2004) The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75(4):678–686

    Article  PubMed  CAS  Google Scholar 

  15. Bouchard L, Weisnagel SJ, Engert JC, Hudson TJ, Bouchard C, Vohl MC, Perusse L (2004) Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec family study. J Endocrinol Invest 27(11):1003–1009

    PubMed  CAS  Google Scholar 

  16. Pizzuti A, Argiolas A, Di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L (2002) An ATG repeat in the 3’-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 87(9):4403–4406

    Article  PubMed  CAS  Google Scholar 

  17. Beckers S, Peeters AV, Freitas F, Mertens IL, Hendrickx JJ, Van Gaal LF, Van Hul W (2008) Analysis of genetic variations in the resistin gene shows no associations with obesity in women. Obesity (Silver Spring) 16(4):905–907

    Article  CAS  Google Scholar 

  18. Nielsen TL, Wraae K, Brixen K, Hermann AP, Andersen M, Hagen C (2006) Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the odense androgen study. Int J Obes (Lond) 30(5):805–815

    Article  CAS  Google Scholar 

  19. Frost M, Wraae K, Gudex C, Nielsen T, Brixen K, Hagen C, Andersen M (2012) Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing 41(2):177–183

    Article  PubMed  Google Scholar 

  20. Ott J (2005) Documentation to LINKAGE UTILITY programs. http://linkage.rockefeller.edu/ott/linkutil.htm. Accessed 16 May 2011

  21. Gauderman WJ, Morrison JM (2006) QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe. Accessed 19 April 2011

  22. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA (2000) Inhibition of adipogenesis by wnt signaling. Science 289(5481):950–953

    Article  PubMed  CAS  Google Scholar 

  23. Piters E, Boudin E, Van Hul W (2008) Wnt signaling: a win for bone. Arch Biochem Biophys 473(2):112–116

    Article  PubMed  CAS  Google Scholar 

  24. Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96(9):2703–2713

    Article  PubMed  CAS  Google Scholar 

  25. Magni P, Dozio E, Galliera E, Ruscica M, Corsi MM (2010) Molecular aspects of adipokine–bone interactions. Curr Mol Med 10(6):522–532

    PubMed  CAS  Google Scholar 

  26. Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52(7):1611–1618

    Article  PubMed  CAS  Google Scholar 

  27. Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY, Park HJ, Shin HD, Park KS (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47(3):559–565

    Article  PubMed  CAS  Google Scholar 

  28. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U, Baroni MG (2002) Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 51(3):860–862

    Article  PubMed  CAS  Google Scholar 

  29. Conneely KN, Silander K, Scott LJ, Mohlke KL, Lazaridis KN, Valle TT, Tuomilehto J, Bergman RN, Watanabe RM, Buchanan TA, Collins FS, Boehnke M (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47(10):1782–1788

    Article  PubMed  CAS  Google Scholar 

  30. Ukkola O, Kesaniemi YA, Tremblay A, Bouchard C (2004) Two variants in the resistin gene and the response to long-term overfeeding. Eur J Clin Nutr 58(4):654–659

    Article  PubMed  CAS  Google Scholar 

  31. Pistilli EE, Gordish-Dressman H, Seip RL, Devaney JM, Thompson PD, Price TB, Angelopoulos TJ, Clarkson PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Hoffman EP, Gordon PM (2007) Resistin polymorphisms are associated with muscle, bone, and fat phenotypes in white men and women. Obesity (Silver Spring) 15(2):392–402

    Article  CAS  Google Scholar 

  32. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149(4):331–335

    Article  PubMed  CAS  Google Scholar 

  33. Kunnari A, Ukkola O, Kesaniemi YA (2005) Resistin polymorphisms are associated with cerebrovascular disease in Finnish type 2 diabetic patients. Diabet Med 22(5):583–589

    Article  PubMed  CAS  Google Scholar 

  34. Huang SW, Seow KM, Ho LT, Chien Y, Chung DY, Chang CL, Lai YH, Hwang JL, Juan CC (2005) Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett 579(2):449–454

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the Novo Nordisk foundation and by a TOP grant from the University of Antwerp to WVH. SB is a postdoctoral fellow of the Research Foundation-Flanders (FWO Vlaanderen). DZ and EB hold predoctoral specialization scholarships from the Agency for Innovation by Science and Technology in Flanders (IWT).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sigri Beckers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beckers, S., Zegers, D., Van Camp, J.K. et al. Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study. Mol Biol Rep 40, 2467–2472 (2013). https://doi.org/10.1007/s11033-012-2327-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2327-z

Keywords

Navigation